Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATION - NEUROONE MEDICAL TECHNOLOGIES Corp | f10k2019ex32-1_neuroonemedi.htm |
| EX-31.1 - CERTIFICATION - NEUROONE MEDICAL TECHNOLOGIES Corp | f10k2019ex31-1_neuroonemedi.htm |
| EX-10.42 - LOCK-UP AGREEMENT DATED OCTOBER 21, 2019, BETWEEN WADE FREDRICKSON AND THE COMPA - NEUROONE MEDICAL TECHNOLOGIES Corp | f10k2019ex10-42_neuroonemedi.htm |
| EX-4.2 - DESCRIPTION OF SECURITIES - NEUROONE MEDICAL TECHNOLOGIES Corp | f10k2019ex4-2_neuroonemedi.htm |
| 10-K - ANNUAL REPORT - NEUROONE MEDICAL TECHNOLOGIES Corp | f10k2019_neuroonemedical.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
NeuroOne Medical Technologies Corporation
Eden Prairie, Minnesota
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-224572) of NeuroOne Medical Technologies Corporation of our report dated December 20, 2019, relating to the consolidated financial statements which appear in this Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/ BDO USA, LLP
Minneapolis, Minnesota
December 20, 2019